![](https://d3ilqtpdwi981i.cloudfront.net/RuQIWd9Ruv6ELNIFY2aWj2a2v78=/425x550/smart/https://bepress-attached-resources.s3.amazonaws.com/uploads/0f/90/05/0f9005b4-43f1-480c-892b-0c26774be2de/thumbnail_9e5e700a-0d94-461c-a2ad-49049a42bb99.jpg)
Article
Bone Health, Pain, and Mobility: Evidence-Based Recommendations for Patients With Multiple Myeloma
Clinical Journal of Oncology Nursing
(2017)
Abstract
BACKGROUND:
About 85% of patients with multiple myeloma develop bone disease. In these patients, lytic bone lesions can cause fractures, poor circulation, blood clots, pain, poor mobility, and decreased quality of life.
.
OBJECTIVES:
This article presents consensus statements to guide nurses in the assessment and management of bone disease, pain, and mobility in patients with multiple myeloma at varying points in their disease trajectory.
.
METHODS:
Members of the International Myeloma Foundation Nurse Leadership Board reviewed previously provided recommendations, current recommendations based on literature review, and evidence-based grading.
.
FINDINGS:
Oncology nurses play a key role in maximizing bone health, minimizing skeletal injury, maximizing pain control, and improving quality of life in patients by enhancing patient mobility and safety. Clinician assessment accompanied by effective interventions reduces patient injury and optimizes functioning in patients with multiple myeloma.
Keywords
- bone health,
- mobility,
- pain,
- myeloma,
- multiple myeloma
Disciplines
Publication Date
Summer July 1, 2017
DOI
10.1188/17.CJON.S5.47-59
Publisher Statement
Download for personal use only
Citation Information
Rome, S., Noonan, K., Bertolotti, P., Tariman, J. D., & Miceli, T. (2017). Bone Health, Pain, and Mobility: Evidence-Based Recommendations for Patients With Multiple Myeloma. Clinical Journal of Oncology Nursing, 21(5), 47-59. doi:10.1188/17.CJON.S5.47-59
Creative Commons license
![Creative Commons License](https://i.creativecommons.org/l/by-nc-nd/4.0/88x31.png)
This work is licensed under a Creative Commons CC_BY-NC-ND International License.